The Angio Suites Market, valued at USD 1,245.0 million in 2022, is projected to grow to USD 2,104.20 million by 2030, with a CAGR of 6.78% from 2023 to 2030. This growth is primarily fueled by the increasing prevalence of cardiovascular diseases globally, necessitating advancements in diagnostic and treatment capabilities.
Advancements in imaging technologies like computed tomography (CT) and magnetic resonance imaging (MRI) are pivotal in improving the accuracy of cardiovascular interventions. These innovations facilitate detailed visualization of blood vessels and cardiac structures, driving the adoption of angio suites for minimally invasive procedures. Moreover, the rising preference for less invasive surgeries among patients and healthcare providers further propels the demand for advanced medical imaging systems such as angio suites, contributing to improved patient outcomes and shorter recovery times.
Market Dynamics
Angio Suites, equipped with advanced imaging technologies such as fluoroscopy and computed tomography (CT), play a critical role in cardiovascular interventions, neurology procedures, and oncology treatments. These suites enable real-time visualization of blood vessels and organs, guiding physicians in performing precise and minimally invasive surgeries, thereby reducing recovery times and hospital stays.
The global angioplasty balloon market was estimated at USD 3.05 billion in 2023 and is projected to reach USD 4.18 billion by 2031, growing at a CAGR of 4.01% during the forecast period 2024-2031.
Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3084
Key Players
Major players in the angioplasty balloon market include:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- Cook Medical Inc.
- Terumo Corporation
- C. R. Bard, Inc. (BD)
- Spectranetics (Philips)
- Endologix, Inc.
- Other players
Market Analysis
The growth of the angioplasty balloon market is driven by several factors:
- Increasing Prevalence of Cardiovascular Diseases: Rise in cardiovascular disorders globally.
- Technological Advancements: Continuous innovations in balloon catheter design and materials.
- Growing Demand for Minimally Invasive Procedures: Preference for non-surgical treatment options.
Key Segments
By Product Type:
- Plain Old Balloon Angioplasty (POBA) Balloons
- Drug-Coated Balloons (DCBs)
- Cutting Balloons
- Scoring Balloons
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Regional Analysis
North America is expected to dominate the angioplasty balloon market due to high healthcare expenditure and technological advancements. Europe and Asia Pacific are anticipated to witness significant growth, driven by increasing adoption of minimally invasive procedures and rising prevalence of cardiovascular diseases.
Key Takeaways
- The angioplasty balloon market is poised for steady growth, driven by the rising burden of cardiovascular diseases and advancements in balloon catheter technology.
- Drug-coated balloons are expected to witness substantial demand, particularly for their efficacy in reducing restenosis rates.
- Hospitals remain the primary end users, accounting for a significant share of market revenue.
Other Related Reports
Cardiac Implants Market Technology
CBD Skin Care Product Market Technology
Cell Reprogramming Market Technology
Cholesterol Test Market Technology
About Us
SNS Insider is a leading market research and consulting agency specializing in global market research. We provide current, accurate market data, consumer insights, and opinions through surveys, video talks, and focus groups.
Contact Us
Akash Anand – Head of Business Development & Strategy
Email: info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: SNS Insider
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian